Crossmark

Human placental mesenchymal stem cells ameliorate chemotherapy-induced damage in the testis by reducing apoptosis/oxidative stress and promoting autophagy

Crossref DOI link: https://doi.org/10.1186/s13287-021-02275-z

Published Online: 2021-03-20

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Lu, Jiafeng

Liu, Zhenxing

Shu, Mingkai

Zhang, Liya

Xia, Wenjuan

Tang, Liuna

Li, Jincheng

Huang, Boxian https://orcid.org/0000-0001-9913-9077
Li, Hong
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (81801515, 81801478)

Suzhou Institute of Nanotechnology, Chinese Academy of Sciences (GSWS2019005)

Suzhou introduce expert team of clinical medicine (SZYJTD201708)

Open project of State Key Laboratory of Reproductive Medicine (SKLRM-K202008)
License Information

Text and Data Mining valid from 2021-03-20

Version of Record valid from 2021-03-20
More Information

Article History

Received: 23 December 2020

Accepted: 9 March 2021

First Online: 20 March 2021

Declarations

:

: The use of human placental mesenchymal stem cells was in accordance with the relevant guidelines, and regulations and the experimental protocols were approved by the Medical Ethics Committee of the Suzhou Hospital Affiliated to Nanjing Medical University.Our investigation using experimental animals and ethical approval were conducted on the basis of the Nanjing Medical University Animal Center’s specific guidelines and standards.We obtained informed consents from the donors.

: Not applicable

: The authors declare no conflicts of interest.

Document is current

Any future updates will be listed below